Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells

Liu, Yuchen, Zeng, Yayue, Liu, Li, Zhuang, Chengle, Fu, Xing, Huang, Weiren, Cai, Zhiming·2014·Nature Communications
DOI 10.1038/ncomms6393

Cited by (223)

Items 101–200 of 223

  1. CRISPR/Cas9-related technologies in liver diseases: from feasibility to future diversity
    Tao Xu, Li Li, Yuchen Liu, Wei William Cao, Jia-si Chen, Shuang Hu, Ying Liu, Liang‐yun Li, Hong Zhou, Xiao‐Ming Meng et al. · 2020 · International Journal of Biological Sciences
  2. A Model for Resource Competition in CRISPR-Mediated Gene Repression
    Pin-Yi Chen, Yili Qian, Domitilla Del Vecchio · 2018 · IEEE Conference on Decision and Control (CDC)
  3. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements
    Ali Nasrallah, Eric Sulpice, Farah Kobaisi, Xavier Gidrol, Walid Rachidi · 2022 · Cells
  4. Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro
    Chengle Zhuang, Changshui Zhuang, Qun Yong Zhou, Xueting Huang, Yaoting Gui, Yongqing Lai, Shangqi Yang · 2021 · Frontiers in Molecular Biosciences
  5. Reinforced plant-derived lipid nanoparticles for oral precise epigenome editing in colonic diseases
    Qiang Gao, Yunxia Gao, Yingui Cao, Haiting Xu, Ya Ma, Menghang Zu, Qiang Yang, KUN YU YANG, Zhenhua Zhu, Chao Liu et al. · 2025 · Science Advances
  6. Putting RNA to work: Translating RNA fundamentals into biotechnological engineering practice
    Gert Peters, Pieter Coussement, Jo Maertens, Jeroen Lammertyn, Marjan De Mey · 2015 · Biotechnology Advances
  7. Programmable Transcriptional Modulation with a Structured RNA-Mediated CRISPR-dCas9 Complex
    Miao He, Xiang Zhou, Zhigang Li, Xue Yin, Wenjie Han, Junxiang Zhou, Xiaoyun Sun, Xiaoyu Liu, Dongbao Yao, Haojun Liang · 2022 · Journal of the American Chemical Society
  8. Synthetic biology strategies towards the development of new bioinspired technologies for medical applications
    Joana L. Rodrigues, Débora Ferreira, Lígia R. Rodrigues · 2016 · Elsevier eBooks
  9. RNAi-mediated control of CRISPR functions
    Xinbo Huang, Zhicong Chen, Yuchen Liu · 2020 · Theranostics
  10. Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637
    Yonghao Zhan, Yuchen Liu, Junhao Lin, Xing Fu, Chengle Zhuang, Li Liu, Wen Xu, Jianfa Li, Mingwei Chen, Guoping Zhao et al. · 2015 · Scientific Reports
  11. Synthetic Gene Circuits: Design, Implement, and Apply
    Andrew Lezia, Arianna Miano, Jeff Hasty · 2021 · Proceedings of the IEEE
  12. Optimization of CRISPR–Cas system for clinical cancer therapy
    Xiang Ling Meng, Tiangang Wu, Qiuyue Lou, Kaiyuan Niu, Lei Jiang, Qing‐zhong Xiao, Tao Xu, Lei Zhang · 2022 · Bioengineering & Translational Medicine
  13. A light/pH/multiple ion-driven smart switchable module for computing sequential logic operations via a resettable dual-optical readout
    Alok Kumar Singh, Promod Kumar Yadav, Niraj Kumari, R. Nagarajan, Lallan Mishra · 2015 · Journal of Materials Chemistry C
  14. Synthetic metabolic computation in a bioluminescence-sensing system
    Natalia Barger, Phyana Litovco, Ximing Li, Mouna Habib, Ramez Daniel · 2019 · Nucleic Acids Research
  15. CRISPR-CasRx Targeting LncRNA LINC00341 Inhibits Tumor Cell Growth in vitro and in vivo
    Chunjing Li, Yu Wen Cao, Li Zhang, Jierong Li, Jianfeng Wang, Yanfen Zhou, Huiling Wei, Mingjuan Guo, Liang Liu, Chunxiao Liu et al. · 2021 · Frontiers in Molecular Biosciences
  16. Engineering of the Epigenome: Synthetic Biology to Define Functional Causality and Develop Innovative Therapies
    Jörg Tost · 2016 · Epigenomics
  17. Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells
    Changping Deng, Shihui Li, Yuping Liu, Wen Bao, Chengnan Xu, Wenyun Zheng, Meiyan Wang, Xingyuan Ma · 2023 · Clinical and Translational Medicine
  18. Engineering the next generation of theranostic biomaterials with synthetic biology
    Xiang Wang, Qianyi Liang, Yixuan Luo, Jianwen Ye, Yin Yu, Fei Chen · 2023 · Bioactive Materials
  19. Genome modularity and synthetic biology: Engineering systems
    Milsee Mol, Ritika Kabra, Shailza Singh · 2017 · Progress in Biophysics and Molecular Biology
  20. Gene surgery
    Ayman El-Meghawry El-Kenawy, Bachir Benarba, Adriana Freitas Neves, Thaise Gonçalves Araújo, Bee Ling Tan, Adel Gouri · 2019 · EXCLI journal
  21. DNA-amphiphilic nanostructures: synthesis, characterization and applications
    Nishkarsh Jain, Ankur Singh, Dhiraj Devidas Bhatia · 2024 · Nanoscale
  22. A Light-Inducible Split-dCas9 System for Inhibiting the Progression of Bladder Cancer Cells by Activating p53 and E-cadherin
    Xinbo Huang, Qun Yong Zhou, Mingxia Wang, Congcong Cao, Qian Ma, Jing Ye, Yaoting Gui · 2021 · Frontiers in Molecular Biosciences
  23. Nanoflare Couple: Multiplexed mRNA Imaging and Logic-Controlled Combinational Therapy
    Yanjing Yang, Tong Luo, Yao He, Zhiwei Deng, Jiacheng Li, Hui Liu, Jing Nie, Wang De, Jin Lin Huang, Shian Zhong · 2022 · Analytical Chemistry
  24. Engineering L7Ae for RNA-Only Delivery Kill Switch Targeting CMS2 Type Colorectal Cancer Cells
    Jiong Yang, Shigang Ding · 2021 · ACS Synthetic Biology
  25. Applications of CRISPR/Cas technology combined with logic gates in molecular detection, genetic engineering, and cancer therapy
    TingTing Xiang, Xianfeng Wang, Li Xiang, Chunxiang Zhang, Jianming Wu, Shiying Zhou · 2025 · Chemical Engineering Journal
  26. Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules
    Rajveer Singh, Shivani Chandel, Arijit Ghosh, Dhritiman Dey, Rudra Chakravarti, Syamal Roy, V. Ravichandiran, Dipanjan Ghosh · 2021 · Molecular Biotechnology
  27. Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors
    Yafeng Wang, Guiquan Zhang, Qingzhou Meng, Shisheng Huang, Panpan Guo, Qibin Leng, Lingyun Sun, Geng Liu, Xingxu Huang, Jianghuai Liu · 2022 · Nature Communications
  28. Design and evaluation of biological gate circuits and their therapeutic applications in a model of multidrug resistant cancers
    Naeimeh Soheili, Mohammad Eshghi, Modjtaba Emadi‐Baygi, Seyed Abbas Mirzaei, Razieh Heidari, Mehdi Hosseinzadeh · 2020 · Biotechnology Letters
  29. An enhanced hTERT promoter-driven CRISPR/Cas9 system selectively inhibits the progression of bladder cancer cells
    Xinbo Huang, Chengle Zhuang, Changshui Zhuang, Tiefu Xiong, Yawen Li, Yaoting Gui · 2017 · Molecular BioSystems
  30. A revolutionary tool: CRISPR technology plays an important role in construction of intelligentized gene circuits
    Qun Yong Zhou, Hengji Zhan, Xinhui Liao, Lan Fang, Yuhan Liu, Haibiao Xie, Kang Yang, Qunjun Gao, Mengting Ding, Zhiming Cai et al. · 2018 · Cell Proliferation
  31. A dual-biomarker-controlled DNA logic platform assisted with multivariate statistical analysis for accurate and high-throughput recognition of cancer cells
    Yanting Feng, Zewei Luo, Juan Wu, Zhijun Huang, Lu He, Yaqiang Feng, Xian Li, Xudong Zhang, Yonghui Tian, Yongxin Li et al. · 2022 · Sensors and Actuators B Chemical
  32. CRISPR Interference Modules as Low-Burden Logic Inverters in Synthetic Circuits
    Massimo Bellato, Angelica Frusteri Chiacchiera, Elia Salibi, Michela Casanova, Davide De Marchi, Ignazio Castagliuolo, Maria Gabriella Cusella De Angelis, Paolo Magni, Lorenzo Pasotti · 2022 · Frontiers in Bioengineering and Biotechnology
  33. From DNA-protein interactions to the genetic circuit design using CRISPR-dCas systems
    Alexey К. Shaytan, Р. В. Новиков, Renat S. Vinnikov, Anna K. Gribkova, Grigory S. Glukhov · 2022 · Frontiers in Molecular Biosciences
  34. Synthetic regulatory RNAs selectively suppress the progression of bladder cancer
    Chengle Zhuang, Xinbo Huang, Changshui Zhuang, Xiaomin Luo, Xiaowei Zhang, Zhiming Cai, Yaoting Gui · 2017 · Journal of Experimental & Clinical Cancer Research
  35. CRISPR-enabled genetic logic circuits for biosensing
    Xiyan Wang, Yuanli Gao, Nan Zhou, Zhugen Yang, Jonathan M. Cooper, Baojun Wang · 2025 · TrAC Trends in Analytical Chemistry
  36. Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells
    Haibiao Xie, Hengji Zhan, Qunjun Gao, Jianfa Li, Qun Yong Zhou, Zhicong Chen, Yuhan Liu, Mengting Ding, Huizhong Xiao, Yuchen Liu et al. · 2018 · Cancer Letters
  37. Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review
    Nikhil H. Samarth, Pooja Gulhane, Shailza Singh · 2022 · Frontiers in Oncology
  38. Retracted Article: Tetracycline-controllable artificial microRNA-HOTAIR + EZH2 suppressed the progression of bladder cancer cells
    Yincong Chen, Haibiao Xie, Yifan Zou, Xiulan Lai, Lian Ma, Yuchen Liu, Jianfa Li · 2017 · Molecular BioSystems · Retracted
  39. A Model for Resource Competition in CRISPR-Mediated Gene Repression
    Chen, Pin-Yi, Yili Qian, Domitilla Del Vecchio · 2018 · DSpace@MIT (Massachusetts Institute of Technology)
  40. CRISPRi-based programmable logic inverter cascade for antibiotic-free selection and maintenance of multiple plasmids
    Seong Keun Kim, Haseong Kim, Seung Gyun Woo, Tae Hyun Kim, Eugene Rha, Kil Koang Kwon, Hyewon Lee, Seung‐Goo Lee, Dae‐Hee Lee · 2022 · Nucleic Acids Research
  41. CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer
    Danielle J. Smith, Sapna Lunj, Antony D. Adamson, Sankari Nagarajan, Timothy Smith, Kimberley Jayne Reeves, Peter Hoskin, Ananya Choudhury · 2024 · Nature Reviews Urology
  42. Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed
    Karim Kanbar, Roy El Darzi, Diana E. Jaalouk · 2024 · Frontiers in Genetics
  43. A Trinity DNAzyme Circuit with Dual‐Confinement Effect for Imaging‐Guided Combined Gene/Chemo‐Dynamic Therapy
    Shuang George Zhao, Xuesong Wang, Ruijia Deng, Xiaoqi Tang, Zuowei Xie, Ping Cheong Huang, Xianlan Wu, Jie Luo, Yu Tang, Jing Sheng et al. · 2025 · Advanced Functional Materials
  44. Gene therapies in clinical trials
    Konstantinos I. Papadopoulos, Phanphen Wattanaarsakit, Weerapong Prasongchean, Ravin Narain · 2016 · Elsevier eBooks
  45. CRISPR-Cas type II-based Synthetic Biology applications in eukaryotic cells
    Mario Andrea Marchisio, Zhiwei Huang · 2017 · RNA Biology
  46. Dual mature microRNA-responsive logic biosensing platform based on CRISPR/Cas12a and DNA nanocage
    Mei Wen, Zhaoxin Huang, Yao Yin, Yin Wang, Menghui Wang, Xueyuan Huang, Ting Chen, Guoliang Ke, Mei Yu Chen, Xiaobing Zhang · 2024 · Talanta
  47. Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells
    Junhao Lin, Yuchen Liu, Yonghao Zhan, Chengle Zhuang, Li Liu, Xing Fu, Wen Xu, Jianfa Li, Mingwei Chen, Zhiming Cai et al. · 2015 · Tumor Biology
  48. Synthetic biology in China: Review and prospects
    Xian‐En Zhang · 2019 · Scientia Sinica Vitae
  49. Translating synthetic gene circuits into the clinic: Challenges, opportunities, and future directions
    Jianli Yin, Xiaoding Ma, Lingfeng Hu, Haifeng Ye · 2025 · Cell Systems
  50. Recent development on synthetic biological devices treating bladder cancer
    Zhicong Chen, Anbang He, Yuchen Liu, Weiren Huang, Zhiming Cai · 2016 · Synthetic and Systems Biotechnology
  51. CRISPR signal conductor 2.0 for redirecting cellular information flow
    Yonghao Zhan, Aolin Li, Congcong Cao, Yuchen Liu · 2022 · Cell Discovery
  52. Linear double‐stranded DNA s as innovative biological parts to implement genetic circuits in mammalian cells
    Weijun Su, Chunze Zhang, Shuai Li · 2019 · FEBS Journal
  53. Mammalian synthetic biology by CRISPRs engineering and applications
    Kenta Katayama, Hitoshi Mitsunobu, Keiji Nishida · 2019 · Current Opinion in Chemical Biology
  54. Programmable Synthetic Protein Circuits for the Identification and Suppression of Hepatocellular Carcinoma
    Xu Han, Jiong Yang, Fanhong Zeng, Jun Weng, Yue Zhang, Qing Peng, Li Shen, Shigang Ding, Kaiyu Liu, Yi Gao · 2020 · Molecular Therapy — Oncolytics
  55. Components of foster care for handicapped children.
    Morton L. Arkava, D N Mueller · 1978 · PubMed
  56. Modular, Synthetic Boolean Logic Gates Enabled in Saccharomyces cerevisiae through T7 Polymerases/CRISPR dCas9 Designs
    Kristin V. Presnell, Omar Melhem, Nicholas J. Morse, Hal S. Alper · 2022 · ACS Synthetic Biology
  57. Synthetic circuits based on split Cas9 to detect cellular events
    Alicja Przybyszewska-Podstawka, Jakub Czapiński, Joanna Kałafut, Adolfo Rivero‐Müller · 2023 · Scientific Reports
  58. Multistable and dynamic CRISPRi-based synthetic circuits
    Javier Santos‐Moreno, Eve Tasiudi, Jörg Stelling, Yolanda Schaerli · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  59. From Boolean Network Model to Continuous Model Helps in Design of Functional Circuits
    Bin Shao, Xiang Liu, Dongliang Zhang, Jiayi Wu, Qi Ouyang · 2015 · PLoS ONE
  60. A fungicide-responsive kinase as a tool for synthetic cell fate regulation
    Kentaro Furukawa, Stefan Hohmann · 2015 · Nucleic Acids Research
  61. A Model for Resource Competition in CRISPR-Mediated Gene Repression
    Pin-Yi Chen, Yili Qian, Domitilla Del Vecchio · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  62. Dynamic Nanostructure‐Based DNA Logic Gates for Cancer Diagnosis and Therapy
    Shiyi Bi, Ruowen Yang, Huangxian Ju, Ying Liu · 2024 · ChemBioChem
  63. Cardiomyocyte engineering: The meeting point of transcription factors, signaling networks, metabolism and function
    Oksana O. Piven, Raminta Vaičiulevičiūtė, Eiva Bernotienė, Paweł Dobrzyń · 2025 · Acta Physiologica
  64. RNP-Based Control Systems for Genetic Circuits in Synthetic Biology Beyond CRISPR
    Trevor R. Simmons, Andrew D. Ellington, Lydia M. Contreras · 2022 · Methods in molecular biology
  65. A sensitive and specific nano-vehicle based on self-amplified dual-input synthetic gene circuit for intracellular imaging and treatment
    Kejun Dong, Wei Zhang, Hao Hu, Shuangshuang Cheng, Yaoqin Mu, Bei Yan, Wan Shu, Longjie Li, Hongbo Wang, Xianjin Xiao · 2022 · Biosensors and Bioelectronics
  66. Engineering precision therapies: lessons and motivations from the clinic
    Mingqi Xie, Mirta Viviani, Martin Fussenegger · 2020 · Synthetic Biology
  67. Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAs
    Shufeng Ma, Jie Lv, Zinan Feng, Zhili Rong, Ying Lin · 2021 · The Journal of Gene Medicine
  68. Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line
    Kasra Arbabi Zaboli, Hossein Rahimi, Jose Thekkiniath, Amir Hossein Taromchi, Saeed Kaboli · 2022 · Folia Histochemica et Cytobiologica
  69. CRISPR-based gene expression platform for precise regulation of bladder cancer
    Tianying Zhan, Xiao Li, Jiumin Liu, Chujin Ye · 2024 · Cellular & Molecular Biology Letters
  70. Preparation and properties of biocompatible and injectable hydrogels for bladder cancer drug delivery
    Xueliang Deng, Dangwei Li, Lemin Chen, Zihan Yu, Jingping Qiu, Xin Teng Liang, Ting Huang, Jue Lan, Rongmin Qiu, Linbin Jiang · 2023 · New Journal of Chemistry
  71. Large scale control and programming of gene expression using CRISPR
    Matthew Deyell, Sandeep Ameta, Philippe Nghe · 2019 · Seminars in Cell and Developmental Biology
  72. Revolutionizing personalized cancer treatment: the synergy of next-generation sequencing and CRISPR/Cas9
    Muniba Mahmood, Izza Taufiq, Sana Mazhar, Faiqa Hafeez, Kausar A. Malik, Samia Afzal · 2024 · Personalized Medicine
  73. Influential Factors and Synergies for Radiation-Gene Therapy on Cancer
    Mei Lin, Junxing Huang, Yujuan Shi, Yanhong Xiao, Ting Guo · 2015 · Analytical Cellular Pathology
  74. The roles of long non‑coding RNAs in renal cell carcinoma (Review)
    ZHENGMING SU, Jian Ao, Fengjin Zhao, Guibin Xu, Huihua Chen, Gao Chen · 2022 · Molecular and Clinical Oncology
  75. Application of synthetic biology in bladder cancer
    Mengting Ding, Jiaxing Lin, Caipeng Qin, Ping Wei, Jiahe Tian, Tianxin Lin, Tao Xu · 2022 · Chinese Medical Journal
  76. SBOLExplorer: Data Infrastructure and Data Mining for Genetic Design Repositories
    Michael Zhang, Zach Zundel, Chris John Myers · 2019 · ACS Synthetic Biology
  77. Hierarchical Assembly of Flexible Biopolymer Polyphosphate‐Manganese into Nanosheets
    Jing Wang, Yucheng Tao, Yewen Juan, Hang Zhou, Xinyang Zhao, Xiaomei Cheng, Xiuxiu Wang, Xuebo Quan, Junyan Li, Kai Huang et al. · 2022 · Small
  78. Targeting RAS-mutant cancer cells using a synthetic RAS-activated cancer killing system
    Fei Teng, Qingqin Gao, Zhou Li, Tongtong Cui, Xiangtian Tan, Yali Ding, Rongqi Li, Bojin Li, Bei Zhong, Miao Miao et al. · 2025 · Trends in biotechnology
  79. Recent advances in nucleic acid nanotechnology-driven artificial transcriptional components
    Kai Jiao, Wenxin Zhai, Hongzhen Peng, Linjie Guo, Jiang Li, Gaozhe Cai, Lihua Wang · 2025 · Nanoscale
  80. Synthetic optogenetic devices for biomedical applications
    Jiawei Shao, Sucheng Zhu, Haifeng Ye, Yuanhuan Yu · 2017 · Scientia Sinica Vitae
  81. A CRISPR-Cas9-Based Therapeutics in Oxidative Stress-Induced Cancer
    Nivya Vijayan, V. P. Venkatiesh, Vani Vijay, Anbarasu Kannan, Baskaran Vallikannan, Madan Kumar Perumal · 2022 · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
  82. Construction of Novel Polymers with Phenyl Substituted Benzodithiophenedione for Photovoltaic Performance Study
    Suinan Deng, Haizhen Liu, Lianjie Zhang, Wenjun Luo, Mei Luo, Zesheng Zhang, Jiahao Liang, Xinkang Wang, Junwu Chen · 2024 · 化学学报
  83. Current Progress in Synthetic Genetic Networks
    Amir Pandi, Heykel Trabelsi · 2020 · Springer eBooks
  84. CRISPR-Cas9 in cancer therapeutics
    Shubhchintan Randhawa · 2021 · Progress in molecular biology and translational science
  85. [Application Progress of CRISPR/Cas9 System for Gene Editing in Tumor Research].
    Chao Liu, Zhiwei Li, Yanqiao Zhang · 2015 · Europe PMC (PubMed Central)
  86. Modular AND Gate‐Controlled Delivery Platform for Tumor Microenvironment Specific Activation of Protein Activity
    Enguo Ju, Faming Wang, Zhenzhen Wang, Chaoying Liu, Kai Dong, Fang Pu, Jinsong Ren, Xiaogang Qu · 2020 · Chemistry - A European Journal
  87. DNA Origami‐Based Single‐Molecule CRISPR Machines for Spatially Resolved Searching
    Yaya Hao, Mingqiang Li, Qian Zhang, Jiye Shi, Jiang Li, Qian Li, Chunhai Fan, Fei Wang · 2022 · Angewandte Chemie
  88. Application of Repetitive Sequences in Fish Cell Depletion as a Target for the CRISPR/Cas9 System
    Yunsheng Zhang, Hu Xia, Wei Peng, Lanhai Liu, Liangguo Liu, Pinhong Yang · 2024 · Marine Biotechnology
  89. “AND” Logic-Gated Biomimetic Nanoparticles to Activate Macrophage Phagocytosis for Cancer Immunotherapy
    Tao Zhang, Jia-Qi Luo, Yubin Liu, Hui-Han Yu, Xin Zhang, Zhen-Hao Zhuang, Lang Rao, Jin‐Zhi Du · 2026 · Nano Letters
  90. CRISPR/Cas9 in cancer research and therapeutics: Clinical applications, optimization strategies, and future perspectives
    Alireza Shariati, Amirreza Homaei, Arya Khezrpour, Nima Azizi, Pouria Khani, Fatemeh Sadat Shariati, Maryam Rafiee, Hamed Afkhami, Mohammad Hasan Yousefi, Farzane Saeidi et al. · 2026 · Current Research in Biotechnology
  91. Programmable living therapeutics for cancer immunotherapy
    Zhenqiang Deng, Li Niu, Zhihao Wang, Yiyu Jin, Zhiyuan Yao, Hang Wan, Ningzi Guan, Haifeng Ye · 2026 · Cell chemical biology
  92. Cellular Therapies: Gene Editing and Next-Gen CAR T Cells
    Thomas James Cradick · 2016 · Springer eBooks
  93. Application of clustered regularly interspersed short palindromic repeats/cas9 editing technologies in breast cancer research
    Fengfeng Cai, Ewelina Maria Biskup, Lu Cai, Xiaoyan Lin, Craig Kingston · 2017 · Translational Surgery
  94. A CRISPR-Cas9-Based Therapeutics in Oxidative Stress-Induced Cancer
    Nivya Vijayan, V. P. Venkatiesh, Vani Vijay, Anbarasu Kannan, Baskaran Vallikannan, Madan Kumar Perumal · 2022 · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
  95. Synthetic Biology Application for Bladder Cancer
    Shiqiang Zhang, Chaoliang Wang, Longlong Fan · 2025 · Journal of Bio-X Research
  96. Регулируемый доксициклином двухпропромоторный интегратор на основе трансактиватора системы TET-ON 3G
    Ю. М. Ходарович, Darya Rakhmaninova, А. М. Барышникова, С. М. Деев · 2020 · Molecular Biology
  97. The intersectional genetics landscape for humans
    André Macedo, Alisson M. Gontijo · 2020 · GigaScience
  98. Delivery Methods for CRISPR/Cas Reagents
    Sidra Ashraf, Nayla Munawar, Muhammad Kashif Zahoor, Amer Jamil, Masooma Hammad, Abdul Ghaffar, Aftab Ahmad · 2022 · Springer eBooks
  99. Therapeutic Applications of CRISPR/Cas9 Technology for Infectious Diseases
    Garima Sharma, Suriya Rehman, Ashish Ranjan Sharma · 2022 · Springer eBooks
  100. Doxycycline Sensitive Two-Promoter Integrator Based on the TET-ON 3G Transactivator
    Yu. M. Khodarovich, Darya Rakhmaninova, A. M. Barishnikova, Sergey Mikhailovich Deyev · 2020 · Molecular Biology